Abbvie Inc. vs Elevance Health, Inc.
ABBV vs ELV — side-by-side comparison from reported financials. ABBV leads 6, ELV leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Elevance Health, Inc.
ELV · Healthcare
$411.70+2.68%Strained
| Metric | ABBV | ELV |
|---|---|---|
| Price | $276.43 | $411.70 |
| Market cap | $488B | $89.3B |
| Revenue (TTM) | $64.4B | $201B |
| Revenue growth | +1.8% | +8.3% |
| Net margin | 9.8% | 2.5% |
| Free cash flow | $18.2B | $6.29B |
| Net cash (debt) | ($56.2B) | $4.43B |
| 1-year price return | +19.8% | +15.0% |
| P/E | 77.4 | 18.0 |
| P/E vs own history (cheap-side %) | 23% | 48% |
| Dividend yield | 2.45% | 1.68% |
| Return on equity | 96% | 11% |
| Altman Z-score | 2.33 | 1.33 |
| CV checks passed | 9 of 11 | 10 of 11 |
| Employees | 57,000 | 97,100 |
Full résumé-style profiles: ABBV CV · ELV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.